Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Shukra Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations
 BSE Code
 524632
ISIN Demat
INE551C01044
Book Value
1.2397304
Mar.Cap(Rs.Cr)
569.24
P/E
68.42
Face Value
1
Go
Your are on :   Markets   |  Company Profile   |  Board Of Directors
Chairman & Managing DirectorDakshesh Shah
Executive DirectorPayal Mehta
Independent DirectorBhoomiben Patel
Sarjeevan Singh
Sonal Deepalbhai Gandhi
Whole Time DirectorSanskruti Patel
Dhruvin Shah
Independent DirectorPinki Nirmal Sagar
Whole Time DirectorAnar Jayesh Patel
Independent DirectorJitendra shah
Company Sec. & Compli. OfficerArpita Kabraa
Independent DirectorRitu Kapoor
Whole Time DirectorSheetal Shah
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0
Investor Charter
STOCK BROKER DEPOSITORY PARTICIPANTS INVESTOR GRIEVANCES ESCALATION MATRIX
Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)